Skip to main content

Trulicity (dulaglutide) shortage

The current Trulicity (dulagutide) supply situation

Eli Lilly have informed the Therapeutic Goods Administration (TGA) that there will be limited availability of Trulicity (dulaglutide) until 31 March 2023. Patients could experience delays of several weeks in having their scripts filled during this time.

We recommend that patients with type 2 diabetes who are unable to fill their script for Trulicity in time for their next dose should contact their doctor immediately to have their treatment plan reassessed. This is especially important as we approach the holiday season, when medical services will be limited for several weeks.

The TGA continues to work with Eli Lilly, pharmaceutical wholesalers and medical professional organisations to provide any solutions possible for patients during this shortage.

The TGA will publish updates about the supply of Trulicity from Eli Lilly on the Medicine Shortage Reports Database.

Published
Last updated

Help us improve the Therapeutic Goods Administration site